Amplifon S.p.A. (IT:AMP)
:AMP
Want to see IT:AMP full AI Analyst Report?
AMP Stock Chart & Stats
€10.12
-€0.43(-1.65%)
At close: 4:00 PM EST
€10.12
-€0.43(-1.65%)
Day’s Range― - ―
52-Week Range€7.84 - €21.40
Previous CloseN/A
Volume722.13K
Average Volume (3M)1.87M
Market Cap
€2.86B
Enterprise Value€3.86B
Total Cash (Recent Filing)€309.56M
Total Debt (Recent Filing)€1.80B
Price to Earnings (P/E)33.8
Beta0.86
Next Earnings
Jul 30, 2026EPS Estimate
0.22Next Dividend Ex-DateN/A
Dividend Yield2.13%
Share Statistics
EPS (TTM)0.31
Shares Outstanding271,688,630
10 Day Avg. Volume1,761,726
30 Day Avg. Volume1,873,340
Financial Highlights & Ratios
PEG Ratio-0.91
Price to Book (P/B)3.12
Price to Sales (P/S)1.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€11.27Price Target Upside11.33% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)0.74
Revenue Forecast (FY)€2.43B
Bulls Say, Bears Say
Bulls Say
Cash GenerationSustained positive TTM operating and free cash flow indicate the core retail/service model still converts revenue into cash. This durable cash generation supports working capital, funding for clinic operations, and servicing debt, giving financial flexibility during recovery periods.
Margin ResilienceA roughly 21% EBITDA margin despite sharp revenue declines implies underlying cost discipline and scalable clinic economics. Durable mid-teens-to-twenties EBITDA margins support viability of the business model and provide a base for restoring net margins as top-line improves.
Scale & Service ModelA large clinic network with bundled device sales plus ongoing service creates recurring revenue, patient stickiness, and supplier negotiating power. Those structural advantages make Amplifon well positioned to defend market share and extract unit economics gains over the medium term.
Bears Say
Revenue MomentumA pronounced ~33.5% TTM revenue drop is a structural concern: it reduces operating leverage, weakens pricing and cross-sell dynamics, and prolongs the timeline to restore scale economics. Top-line weakness undermines durable earnings and cash-flow trajectories.
Elevated LeverageMaterial leverage for a service-led medical device retailer increases financial risk as profitability weakens. Higher debt burdens interest and limits flexibility for strategic investments, acquisitions, or smoothing through revenue troughs, making recovery dependent on margin improvement.
Compressed Profitability / ROEFalling net margins and a halved ROE reflect erosion in earnings power. Persistently lower profitability reduces retained earnings growth, constrains reinvestment, and makes it harder to deleverage without sustained revenue recovery or structural margin initiatives.
Amplifon S.p.A. News
AMP FAQ
What was Amplifon S.p.A.’s price range in the past 12 months?
Amplifon S.p.A. lowest stock price was €7.84 and its highest was €21.40 in the past 12 months.
What is Amplifon S.p.A.’s market cap?
Amplifon S.p.A.’s market cap is €2.86B.
When is Amplifon S.p.A.’s upcoming earnings report date?
Amplifon S.p.A.’s upcoming earnings report date is Jul 30, 2026 which is in 51 days.
How were Amplifon S.p.A.’s earnings last quarter?
Amplifon S.p.A. released its earnings results on May 05, 2026. The company reported €0.2 earnings per share for the quarter, beating the consensus estimate of €0.196 by €0.004.
Is Amplifon S.p.A. overvalued?
According to Wall Street analysts Amplifon S.p.A.’s price is currently Undervalued.
Does Amplifon S.p.A. pay dividends?
Amplifon S.p.A. pays a Annually dividend of €0.29 which represents an annual dividend yield of 2.13%. See more information on Amplifon S.p.A. dividends here
What is Amplifon S.p.A.’s EPS estimate?
Amplifon S.p.A.’s EPS estimate is 0.22.
How many shares outstanding does Amplifon S.p.A. have?
Amplifon S.p.A. has 271,688,630 shares outstanding.
What happened to Amplifon S.p.A.’s price movement after its last earnings report?
Amplifon S.p.A. reported an EPS of €0.2 in its last earnings report, beating expectations of €0.196. Following the earnings report the stock price went up 4.598%.
Which hedge fund is a major shareholder of Amplifon S.p.A.?
Currently, no hedge funds are holding shares in IT:AMP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Amplifon S.p.A.
Amplifon S.p.A. delivers extensive hearing care products and services, empowering individuals to reconnect with the world of sound. Their diverse selection of hearing devices includes models such as ampli-easy, ampli-mini, ampli-connect, and ampli-energy, complemented by personalized fitting services for tailored solutions. As of March 18, 2022, the company maintained a substantial global presence, operating approximately 9,200 retail locations across 25 countries and five continents, further extending its reach through 1,350 franchised outlets. Amplifon conducts operations throughout Europe, the Middle East, Africa, the United States, Asia, and Oceania. The company, established in 1950, is headquartered in Milan, Italy.
AMP Stock 12 Month Forecast
Average Price Target
€11.27
▲(11.33% Upside)
Technical Analysis
Options Prices
Currently, No data available
---